FDA Inspection 1345522 — Gland Pharma Limited

Gland Pharma Limited — FEI 3009056604

The FDA completed an inspection of Gland Pharma Limited on Sep 1, 2026 in Visakhapatnam. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 1, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Visakhapatnam (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.